MEDPLUS, INC. ANNOUNCES STOCK REPURCHASE PROGRAM, MANAGEMENT
CHANGES AND EXPECTATION OF OPERATING LOSS FOR THE FOURTH QUARTER

November 5, 1996, MedPlus, Inc.(NASDAQ: MEDP) announced today that
the Board of Directors has authorized a common stock repurchase
program. The timing of the program and the amount of stock
repurchased will be directed by overall financial and market
conditions. The Board has authorized management to repurchase up
to 500,000 shares in the open market commencing on or after
November 6, 1996, and management will review the repurchase
program on a regular basis.  Richard A. Mahoney stated that "this
program allows us to repurchase shares at very attractive prices.
The repurchased shares will be held as treasury shares and will be
available for general corporate purposes.  This action reflects
the confidence that both the Board and management have in the
future of MedPlus."  At September 30, 1996, MedPlus had working
capital of approximately $6,700,000, shareholders' equity of
approximately $11,000,000 and an unused line of credit of
$10,000,000.

The Company also announced that effective immediately, Gary L.
Price will become Senior Vice President of Business Development. 
This move will utilize Price's sales and management expertise to
better position the Company in the area of new strategic business
relationships as well as managing existing business partnerships
such as Sunquest Information Systems, Shared Medical Systems,
Abbott Laboratories and Transcend Services, Inc. The creation of
the business development position is recognition that strategic
relationships that supplement the direct sales organization have
become a more critical factor in achieving both industry
visibility and market share. Timothy P. McMullen will become Vice
President of Sales, with overall responsibility for recruitment,
training and management of the Company's sales organization. Prior
to joining MedPlus in June of this year as Vice President of
Corporate Accounts and Managed Care, McMullen held that same title
for Hill-Rom, a wholly-owned subsidiary of Hillenbrand Industries
located in Batesville, Indiana.  During his fifteen year tenure
with Hill-Rom, McMullen managed both the domestic and
international sales operations and the sales support and marketing
functions.

MedPlus also announced that it expected that the fourth quarter
results of operations will result in a loss for the period.  The
expected performance relates to the longer than anticipated sales
cycles of the Company's ChartMaxx Electronic Patient Record System
which will result in lower than forecasted revenues for this
product.  As disclosed last week in the Company's third quarter
earnings release, management believes that the market potential
for this product continues to be substantial and the Company has
continued to increase its sales, marketing and administrative
expenses to support the installation and development efforts when
additional contracts are secured.  The Company also communicated
its intention in the future to significantly reduce operating
expenses as a percentage of net revenues and increase operating
expenses only when supported by higher revenue levels.

MedPlus is a publicly-traded, Cincinnati-based company that
develops, sells and supports hardware and software solutions to
meet the needs of health care organizations. Product offerings
include electronic patient record systems, optical document
archival and retrieval systems, intelligent bar coding systems,
object-oriented workflow and document management systems and
laboratory, business office and physician office integration
services.